HAEMONETICS CORP — Director's Dealing 2014

Oct 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2014-10-27

Reporting Person: Helsel Dave (EVP, Global Manufacturing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-27	Common Stock	D	251.0	$35.92	Disposed	13123	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.